IGF1 and neoplasm: IGF-1 is overexpressed in SFT, and treatment regimens using figitumumab, a fully human IgG2 anti-IGF-1 (IGF-1R) monoclonal antibody, demonstrated tumor responses in a few patients with advanced SFTs [106,112].